Neurotransmitter Receptor Influence on Behavior
Research Guide

Dopamine in reward circuitry drives drug craving via incentive-sensitization, as outlined in "The neural basis of drug craving: An incentive-sensitization theory of addiction" by Robinson and Berridge (1993). Koob and Volkow (2009) in "Neurocircuitry of Addiction" detail how dopamine alterations in the prefrontal cortex and basal ganglia sustain compulsive drug-seeking. These mechanisms link receptor sensitization to persistent behavioral changes in addiction models.

A polymorphism in the serotonin transporter gene regulatory region associates with anxiety-related traits in humans and animal models, as shown by Lesch et al. (1996) in "Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region". This variant modulates 5-HTT transcription, influencing uptake-inhibiting antidepressant efficacy. The finding supports genetic contributions to anxiety vulnerability.

The elevated plus-maze validates open:closed arm entries as a measure of anxiety in rats, per Pellow et al. (1985) in "Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat". Fewer open arm entries indicate higher anxiety linked to serotonin and GABA receptor activity. This model standardizes behavioral assessment of anxiolytic drug effects.

In chronic schizophrenia patients, olanzapine had the lowest discontinuation rates due to efficacy, while perphenazine matched atypicals in efficacy but had fewer metabolic side effects, according to Lieberman et al. (2005) in "Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia". Most discontinuations occurred from inefficacy or side effects across groups. These dopamine receptor findings guide long-term pharmacotherapy.

Endophenotypes are measurable neurophysiological, biochemical, or neuroanatomical traits along the pathway from genotype to disease phenotype, as defined by Gottesman and Gould (2003) in "The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions". They aid in dissecting complex neuropsychiatric disorders like addiction and depression. Receptor-mediated endophenotypes bridge genetics and behavior.

Anandamide, an arachidonylethanolamide from porcine brain, binds the cannabinoid receptor, as isolated by Devane et al. (1992) in "Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor". Its structure was confirmed by mass spectrometry and NMR. This endogenous ligand influences reward and compulsive behaviors via receptor activation.